---
title: Extracorporeal Life Support in Infarct-Related Cardiogenic Shock
date: '2023-08-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37634145/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&fc=20211015124055&ff=20230828184236&v=2.17.9.post6+86293ac
source: N Engl J Med
description: 'CONCLUSIONS: In patients with acute myocardial infarction complicated
  by cardiogenic shock with planned early revascularization, the risk of death from
  any cause at the 30-day follow-up was not lower among the patients who received
  ECLS therapy than among those who received medical therapy alone. (Funded by the
  Else Kröner Fresenius Foundation and others; ECLS-SHOCK ClinicalTrials.gov number,
  ...'
disable_comments: true
---
CONCLUSIONS: In patients with acute myocardial infarction complicated by cardiogenic shock with planned early revascularization, the risk of death from any cause at the 30-day follow-up was not lower among the patients who received ECLS therapy than among those who received medical therapy alone. (Funded by the Else Kröner Fresenius Foundation and others; ECLS-SHOCK ClinicalTrials.gov number, ...